S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
Log in

Remedent Stock Forecast, Price & News

-0.06 (-28.42 %)
(As of 03/2/2021 12:00 AM ET)
Today's Range
Now: $0.15
50-Day Range
MA: $0.19
52-Week Range
Now: $0.15
Volume104 shs
Average Volume2,609 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Remedent, Inc., through its subsidiaries, researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products. It primarily provides professional veneers and teeth whitening products for professional and over-the-counter use. The company offers River8, a prefab veneer that enables the dentist to find the right combination of teeth for a patient with minor reshaping. It also provides GlamSmile veneers, which are ultra-thin claddings attached to the front of the patient's teeth. In addition, the company offers SmileMe Mirror, an integrated marketing concept for the dental practice, which enables dentists to offer smile consultation in approximately 10 minutes; SmileSketch, a simulation software to make a sketch of what the patient could look like; and various Treatment Pages to explain the benefits of certain treatments, as well as Condor, an intra-oral 3D scanner. Further, it provides dental implant solutions and treatment concepts. The company sells its products to dental professionals in approximately 30 countries, including Asia, Europe, the Middle East, Canada, and the United States through its internal sales force and third party distributors. The company was founded in 1986 and is headquartered in Ghent, Belgium.
Remedent logo

Industry, Sector and Symbol

Industry Dental equipment & supplies
Current SymbolOTCMKTS:REMI
Year FoundedN/A



Sales & Book Value

Annual Sales$1.06 million
Cash Flow$0.10 per share
Book Value$0.27 per share


Net Income$-860,000.00


Next Earnings Date3/5/2021 (Estimated)
OptionableNot Optionable


Overall MarketRank

0.59 out of 5 stars

Medical Sector

1362nd out of 1,968 stocks

Dental Equipment & Supplies Industry

7th out of 8 stocks

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
-0.06 (-28.42 %)
(As of 03/2/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive REMI News and Ratings via Email

Sign-up to receive the latest news and ratings for REMI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Remedent (OTCMKTS:REMI) Frequently Asked Questions

What stocks does MarketBeat like better than Remedent?

Wall Street analysts have given Remedent a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Remedent wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Remedent's next earnings date?

Remedent is scheduled to release its next quarterly earnings announcement on Friday, March 5th 2021.
View our earnings forecast for Remedent

How has Remedent's stock been impacted by COVID-19?

Remedent's stock was trading at $0.19 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, REMI shares have decreased by 20.5% and is now trading at $0.1511.
View which stocks have been most impacted by COVID-19

Who are Remedent's key executives?

Remedent's management team includes the following people:
  • Mr. Guy De Vreese, Chairman & CEO (Age 66)
  • Mr. Philippe Van Acker, CFO, Chief Accounting Officer & Director (Age 56, Pay $192.76k)
  • Mr. Mark E. Sernatinger, Exec. Officer of United States Office
  • Mr. Scott G. Juhl, Exec. Officer of United States Office
  • Mr. Stacey J. Ammons, Exec. Officer of United States Office

Who are some of Remedent's key competitors?

What other stocks do shareholders of Remedent own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Remedent investors own include CoStar Group (CSGP), Enterprise Products Partners (EPD), Kellogg (K), MKS Instruments (MKSI), M&T Bank (MTB), Old Line Bancshares (OLBK), RH (RH), AT&T (T), Taiwan Semiconductor Manufacturing (TSM) and (VC).

What is Remedent's stock symbol?

Remedent trades on the OTCMKTS under the ticker symbol "REMI."

How do I buy shares of Remedent?

Shares of REMI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Remedent's stock price today?

One share of REMI stock can currently be purchased for approximately $0.15.

How many employees does Remedent have?

Remedent employs 2 workers across the globe.

What is Remedent's official website?

The official website for Remedent is www.remedent.com.

Where are Remedent's headquarters?

Remedent is headquartered at BELGIUM ZUIDERLAAN 1-3 BUS 8, GHENT C9, 9000.

How can I contact Remedent?

Remedent's mailing address is BELGIUM ZUIDERLAAN 1-3 BUS 8, GHENT C9, 9000. The company can be reached via phone at 011-32-9241-5880.

This page was last updated on 3/4/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.